Publications by authors named "Sarah M Konrad"
Article Synopsis
- Scientists are studying a protein called NCALD to see if it can help predict how well patients with ovarian cancer will respond to a type of treatment called platinum-based chemotherapy.
- They found that patients with higher levels of NCALD tended to live longer after treatment, which suggests that NCALD could be important for doctors to know about.
- If patients have low levels of NCALD, they may not respond as well to the chemotherapy, indicating NCALD might help identify who will benefit most from this treatment.
